TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20100903

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus trimetazidine (TMZ)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy alone (Control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus trimetazidine (TMZ) in ischemic patients
Number of subjects: 30
Study: 18379485

Group type: EXPERIMENTAL
Intervention: Bitemporal transcranial magnetic therapy
Number of subjects: 88
Study: 16251627

Group type: EXPERIMENTAL
Intervention: Serum ferritin concentrations > 160 microg/L in women
Number of subjects: 10197

Group type: COMPARATOR
Intervention: Baseline serum transferrin and serum ferritin concentrations
Number of subjects: 10197

Group type: COMPARATOR
Intervention: Baseline serum ferritin and serum transferrin concentrations
Number of subjects: 10197

Group type: COMPARATOR
Intervention: Dietary iron intake
Number of subjects: 10197
Study: 11934682

Group type: EXPERIMENTAL
Intervention: Low-dose IGF-I therapy (40 microg.kg(‐1).day(‐1))
Number of subjects: 12
Study: 9473015

Group type: EXPERIMENTAL
Intervention: Zidovudine 500 mg/day
Number of subjects: 154

Group type: COMPARATOR
Intervention: No antiretroviral treatment
Number of subjects: 154
Study: 8539088

Group type: EXPERIMENTAL
Intervention: Familiar faces (congruent)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfamiliar faces (incongruent)
Number of subjects: 0
Study: 1760362

Group type: EXPERIMENTAL
Intervention: UVA therapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: UVB therapy
Number of subjects: 21
Study: 7053654

Group type: EXPERIMENTAL
Intervention: Hill antireflux procedure
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Belsey antireflux procedure
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Nissen antireflux procedure
Number of subjects: 391

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 391
Study: 31075056

Group type: EXPERIMENTAL
Intervention: Prenatal surgery
Number of subjects: 156

Group type: COMPARATOR
Intervention: Postnatal surgery
Number of subjects: 156
Study: 26587725

Group type: EXPERIMENTAL
Intervention: Left circumflex (LCX) culprit
Number of subjects: 9406

Group type: EXPERIMENTAL
Intervention: Right coronary artery (RCA) culprit
Number of subjects: 9406

Group type: EXPERIMENTAL
Intervention: Left anterior descending (LAD) culprit
Number of subjects: 9406

Group type: COMPARATOR
Intervention: Culprit artery (LCX, LAD, RCA)
Number of subjects: 9406
Study: 24482383

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 405

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Ticagrelor (discontinued ≥5 days before surgery)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Clopidogrel (discontinued ≥5 days before surgery)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Ticagrelor (discontinued 2-4 days before surgery)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Clopidogrel (discontinued 2-4 days before surgery)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Ticagrelor (discontinued 0-1 day before surgery)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Clopidogrel (discontinued 0-1 day before surgery)
Number of subjects: 405
Study: 22362058

Group type: EXPERIMENTAL
Intervention: Pictorial health warnings with graphic depictions of disease
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Pictorial health warnings with symbolic images or experiences of human suffering
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Pictorial warnings with testimonial information
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Text-only warnings
Number of subjects: 1072
Study: 20811658

Group type: EXPERIMENTAL
Intervention: 21 mg NRT
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: 42 mg NRT
Number of subjects: 369
Study: 17245057

Group type: EXPERIMENTAL
Intervention: Skeeter drill technique
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: CO(2) laser technique
Number of subjects: 336
Study: 15588744

Group type: EXPERIMENTAL
Intervention: Minimization allocation method
Number of subjects: 2158

Group type: EXPERIMENTAL
Intervention: Dynamic allocation (minimization)
Number of subjects: 2158

Group type: EXPERIMENTAL
Intervention: Adjusted tests for allocation factors as covariates
Number of subjects: 2158
Study: 12040250

Group type: EXPERIMENTAL
Intervention: Calcium antagonist (Ca‐A)
Number of subjects: 9000

Group type: EXPERIMENTAL
Intervention: Angiotensin‐converting enzyme inhibitor (ACE‐I)
Number of subjects: 9000

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor antagonist (ARB)
Number of subjects: 9000
Study: 9803001

Group type: EXPERIMENTAL
Intervention: Retroperitoneal approach (group A)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Inguinal approach (group B)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Subinguinal approach (group C)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Percutaneous venous embolization (group D)
Number of subjects: 88
Study: 7662980

Group type: EXPERIMENTAL
Intervention: Hypermetaphase fluorescence in situ hybridization (HMF)
Number of subjects: 70
Study: 2183485

Group type: EXPERIMENTAL
Intervention: Etappenlavage with Velcro analogue for temporary abdominal closure
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Etappenlavage with various closure methods (retention sutures, zipper, slide fastener, Velcro analogue)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Etappenlavage
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Velcro analogue
Number of subjects: 117
Study: 7398184

Group type: EXPERIMENTAL
Intervention: Clonidine 0.3 mg
Number of subjects: 5
Study: 31164368

Group type: EXPERIMENTAL
Intervention: 6-month hybrid closed-loop insulin delivery
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care (conventional or sensor-augmented pump therapy)
Number of subjects: 130
Study: 28231777

Group type: EXPERIMENTAL
Intervention: Communication training for personnel and group intervention for patients addressing patient skills for shared decision making (SDM).
Number of subjects: 276

Group type: COMPARATOR
Intervention: Control condition with treatment as usual.
Number of subjects: 276
Study: 25872651

Group type: EXPERIMENTAL
Intervention: Intervention group (told they were in an intervention trial)
Number of subjects: 6788

Group type: COMPARATOR
Intervention: Control group (told they were in an intervention trial and were in the control group)
Number of subjects: 6788

Group type: COMPARATOR
Intervention: Cohort group (told their drinking would be assessed at baseline and again in one month)
Number of subjects: 6788

Group type: COMPARATOR
Intervention: Cohort group
Number of subjects: 6788

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6788

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 6788
Study: 24064125

Group type: EXPERIMENTAL
Intervention: Repeat Whole Lung Lavage (RWLL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Whole Lung Lavage (WLL)
Number of subjects: 60
Study: 21861771

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 19651542

Group type: EXPERIMENTAL
Intervention: eFlow rapid nebulizer
Number of subjects: 25

Group type: COMPARATOR
Intervention: LC PLUS nebulizer
Number of subjects: 25
Study: 17434812

Group type: EXPERIMENTAL
Intervention: Participation in clinical RCT (group 1a)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Randomisation acceptance (group 1a)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Willingness to participate in hypothetical RCT
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Patient group allocation
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Medical decision-making preferences
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Feeling of being unable to refuse a doctor's proposal
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Satisfaction with doctors' communication
Number of subjects: 455
Study: 15067257

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment need assessed by the aesthetic component (AC) of the index of orthodontic treatment need (IOTN)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment need assessed by the dental health component (DHC) of the index of orthodontic treatment need (IOTN)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Subjective need for orthodontic treatment as assessed by a prestructured questionnaire
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Children's perceptions of dental attractiveness based on intraoral photographs
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Children's perceptions of unattractiveness based on photographs showing severe deviations including crowding
Number of subjects: 386
Study: 11448721

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9713781

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) 0.4 mg/mL for 2 minutes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control balanced salt solution
Number of subjects: 25
Study: 7993985

Group type: EXPERIMENTAL
Intervention: Single 750 mg oral dose of Vigabatrin (VGB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard two-stage techniques
Number of subjects: 0
Study: 2678255

Group type: EXPERIMENTAL
Intervention: Endosonography (ES)
Number of subjects: 171
Study: 1069012

Group type: EXPERIMENTAL
Intervention: Apically repositioned flap operation including elimination of bony defects
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Apically repositioned flap operation including curettage of the bony defects but without removal of bone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Widman flap technique including elimination of bony defects
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Widman flap technique including curettage of the bony defects but without removal of bone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Gingivectomy including curettage of the bony defects but without removal of bone
Number of subjects: 50
Study: 31063868

Group type: EXPERIMENTAL
Intervention: Adaptive goal-setting and incentive interventions for MVPA
Number of subjects: 512

Group type: COMPARATOR
Intervention: Static-goal-setting and delayed-incentive comparisons
Number of subjects: 512
Study: 28599636

Group type: EXPERIMENTAL
Intervention: Health coaching intervention over 9 months focusing on disease understanding, symptom awareness, inhaler use, personalized plans for physical activity, smoking cessation, and care coordination.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health coaching intervention
Number of subjects: 0
Study: 25313850

Group type: EXPERIMENTAL
Intervention: Supine position for 6 hours followed by right lateral position for 6 hours
Number of subjects: 34

Group type: COMPARATOR
Intervention: Supine position throughout the study
Number of subjects: 34
Study: 23878838

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (various durations and frequencies)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cigarette smoking for 4-7 years
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cigarette smoking for 7-11 cigarettes/day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (increased duration and frequency)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonsmoking (control group)
Number of subjects: 100
Study: 21864846

Group type: EXPERIMENTAL
Intervention: HRC monitoring displayed
Number of subjects: 3003

Group type: COMPARATOR
Intervention: Control group (HRC monitoring masked)
Number of subjects: 3003
Study: 19186716

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with moxibustion on temperature-sensitive points
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 60
Study: 17367318

Group type: EXPERIMENTAL
Intervention: Optimal primary surgery
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Nonoptimal primary surgery
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by surgery
Number of subjects: 109

Group type: COMPARATOR
Intervention: No cytoreductive surgical procedure
Number of subjects: 109
Study: 14736303

Group type: EXPERIMENTAL
Intervention: Spatial updating with imagined heading parallel to learning view
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spatial updating with actual and imagined headings the same
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of angular difference between learning heading and imagined heading
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of angular difference between actual heading and imagined heading
Number of subjects: 0
Study: 11286526

Group type: EXPERIMENTAL
Intervention: Maximal exercise cycle test
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Submaximal 6 min walk test
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Endurance treadmill test
Number of subjects: 30
Study: 9441288

Group type: EXPERIMENTAL
Intervention: Sodium-lithium cotransport (SLC) activity in patients with IDDM complicated with diabetic nephropathy (group II)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sodium-lithium cotransport (SLC) activity in patients with IDDM without nephropathy (group I)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sodium-lithium cotransport (SLC) activity in patients treated with hemodialysis due to non-diabetic nephropathy (group III)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sodium-lithium cotransport (SLC) activity in healthy subjects (group IV)
Number of subjects: 51
Study: 8201477

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine (containing PT‐9K/129G, filamentous hemagglutinin, and pertactin)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Whole-cell pertussis vaccine
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 480
Study: 3318196

Group type: EXPERIMENTAL
Intervention: Verapamil‐HCl as Isoptin RR 240 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Veramex SR 240
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: durasoptin SR 240
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison of the three formulations
Number of subjects: 14
Study: 29358543

Group type: EXPERIMENTAL
Intervention: Text message reminders about oral hygiene
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no text message reminders)
Number of subjects: 60
Study: 27699563

Group type: EXPERIMENTAL
Intervention: Subcuticular sutures
Number of subjects: 401

Group type: COMPARATOR
Intervention: Staples
Number of subjects: 401
Study: 25595921

Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient care programme (4 weeks duration)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Usual care (conventional care)
Number of subjects: 514
Study: 23742961

Group type: EXPERIMENTAL
Intervention: Partial Breast Irradiation (PBI)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Whole Breast Irradiation (WBI)
Number of subjects: 258
Study: 20528820

Group type: EXPERIMENTAL
Intervention: Binge drinking (defined as > or =5 drinks on 1 occasion for men or > or =4 drinks on 1 occasion for women)
Number of subjects: 200587

Group type: EXPERIMENTAL
Intervention: Heavy drinking (defined as an average of >14 drinks per week for men or >7 drinks per week for women)
Number of subjects: 200587

Group type: COMPARATOR
Intervention: Nonbinge drinkers
Number of subjects: 200587
Study: 18458186

Group type: EXPERIMENTAL
Intervention: Educational young child-oriented media
Number of subjects: 154

Group type: COMPARATOR
Intervention: Noneducational young child-oriented programs
Number of subjects: 154

Group type: COMPARATOR
Intervention: School-age/teenage/adult-oriented programs
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Coviewed educational content
Number of subjects: 154
Study: 17148703

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparins (e.g., Dalteparin, Enoxaparin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thromboprophylaxis as recommended by American College of Chest Physicians
Number of subjects: 0
Study: 14671179

Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone
Number of subjects: 100
Study: 11967820

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 6 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Irbesartan 123 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Valsartan 93.5 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Telmisartan 54 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 48
Study: 8633602

Group type: EXPERIMENTAL
Intervention: Mobility impairment (balance, leg-extension strength, gait)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Dizziness upon standing
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: History of stroke
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Poor mental state
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Postural hypotension
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Risk profile including all five risk factors
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Number of falls in the previous year
Number of subjects: 354
Study: 1280715

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 20
Study: 3904315

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ritodrine
Number of subjects: 0
Study: 29793876

Group type: EXPERIMENTAL
Intervention: Intensive Group (IG) - Vocal Therapy, 4 times a week for 16 sessions
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional Group - Vocal Therapy, 2 times a week for 16 sessions
Number of subjects: 27
Study: 30404619

Group type: EXPERIMENTAL
Intervention: Enhanced implementation strategy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Core implementation strategy
Number of subjects: 12
Study: 27938918

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 24585423

Group type: EXPERIMENTAL
Intervention: Postoperative patching
Number of subjects: 61

Group type: COMPARATOR
Intervention: No patching (Control)
Number of subjects: 61
Study: 22103958

Group type: EXPERIMENTAL
Intervention: Combination pharmacotherapy (nicotine patch + nicotine lozenge, bupropion + nicotine lozenge)
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Monotherapy (nicotine patch, nicotine lozenge, bupropion)
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Combination treatments
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Suppression of craving on the quit day
Number of subjects: 1504
Study: 19856202

Group type: EXPERIMENTAL
Intervention: Low fat (20% of energy), average protein (15% of energy)
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: High fat (40%), average protein (15%)
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Low fat (20%), high protein (25%)
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: High fat (40%), high protein (25%)
Number of subjects: 811
Study: 18019397

Group type: EXPERIMENTAL
Intervention: Pycnogenol (Pyc)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study: 16361855

Group type: EXPERIMENTAL
Intervention: AST-120 (charcoal compound), dosage and duration not specified
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum (enteric capsules), dosage and duration not specified
Number of subjects: 0
Study: 12967792

Group type: EXPERIMENTAL
Intervention: Verteporfin therapy (Visudyne, Novartis AG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 10948819

Group type: EXPERIMENTAL
Intervention: 600 mg lactoferrin
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 2000 mg lactoferrin
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8773736

Group type: COMPARATOR
Intervention: Carbohydrates (CH; 200 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Saturated fatty acids (SAFA; 72%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acids (PUFA; 60%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cis-monounsaturated fatty acids (MUFA; 40%)
Number of subjects: 8
Study: 1734249

Group type: EXPERIMENTAL
Intervention: Prophylactic nonabsorbable antibiotics (tobramycin, colistin sulfate, and amphotericin B) administered through a nasogastric tube
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo administered through a nasogastric tube
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Prophylactic nonabsorbable antibiotics
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study: 6094447

Group type: EXPERIMENTAL
Intervention: Single dose of cefotaxime, 1 g preoperatively
Number of subjects: 136

Group type: COMPARATOR
Intervention: Multiple doses of cefoxitin, 2 g preoperatively followed by 2 g every 6 h for no more than 24 h
Number of subjects: 136
Study: 31429950

Group type: EXPERIMENTAL
Intervention: Zero-balance ultrafiltration (Z-BUF) of the priming blood with 0.45% saline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no Z-BUF)
Number of subjects: 60
Study: 31735786

Group type: EXPERIMENTAL
Intervention: Collaborative Management (CM) with telemonitoring for 12 months
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Collaborative Management (CM)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Self-Management (SM)
Number of subjects: 59
Study: 29037617

Group type: EXPERIMENTAL
Intervention: Strength Training Program (STP) using rubber band exercises, 18 sessions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (D control)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (ND control)
Number of subjects: 25
Study: 26294416

Group type: EXPERIMENTAL
Intervention: 4 mini-implants
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 2 mini-implants
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2 standard implants
Number of subjects: 120
Study: 23186610

Group type: EXPERIMENTAL
Intervention: Animal Fun program
Number of subjects: 511
Study: 21922233

Group type: EXPERIMENTAL
Intervention: IEGM-based optimization
Number of subjects: 48

Group type: COMPARATOR
Intervention: Echocardiography optimization
Number of subjects: 48
Study: 19160729

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0